RETATRUTIDE 20mg "PEN"

Retatrutide is an investigational, once-weekly triple hormone receptor agonist developed by Eli Lilly for scientific and clinical research. It is a single synthetic peptide molecule designed to activate three distinct receptor pathways: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon.

Retatrutide represents a next-generation approach to multi-receptor peptide research and is being investigated in Phase 3 clinical programmes covering metabolic and cardiometabolic conditions.

Alph4Labs’ Retatrutide 20mg is supplied in a pre-filled pen format and is manufactured for research purposes only, with batch-specific analytical documentation supporting identity, purity, and traceability.

Scientific Name

Retatrutide — GIP / GLP-1 / glucagon triple receptor agonist

Research classification: Synthetic multi-receptor peptide agonist

Specifications

The material is supplied in a sealed 20 mg pen-format presentation, with batch-specific documentation supporting identification, traceability, and laboratory inventory control.

• Compound: Retatrutide

• Scientific name: Retatrutide

• Format: Pre-filled pen

• Content: 20 mg

• Purity: >99% — UK independent external laboratory verified*

• Storage: Refrigerated and protected from light

• Batch: Unique batch reference with supporting documentation

• Research classification: Investigational triple receptor agonist
  

Research Grade

For research purposes only. Retatrutide remains an investigational compound and has not been approved by the FDA. It is not intended for human or veterinary use, self-administration, diagnosis, treatment, or consumption.

Highlights

• Format: Advanced 20 mg pen presentation

• Product: Next-generation multi-receptor peptide research compound

• Purity: >99% — independently verified by a UK external laboratory*

• Traceability: Batch-specific documentation provided

• Testing: Identity and purity analytical verification

• Research focus: GIP, GLP-1 and glucagon receptor signalling and related metabolic research

• Shipping: FREE shipping on all products. Ships within 24 hours.

*Subject to the corresponding batch Certificate of Analysis.

PRODUCT USE DISCLAIMER

Alph4Labs Retatrutide is supplied strictly as a research compound for laboratory and scientific research purposes only. Retatrutide is an investigational molecule and is not an approved medicine. The product is not intended for human or veterinary administration, self-injection, consumption, diagnosis, treatment, or prevention of any disease or medical condition.